---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-040826"
form_type: "8-K"
ticker: "NRXS"
cik: "0001933567"
company_name: "Neuraxis, INC"
filed_at: "2023-11-14T23:59:59+00:00"
generated_at: "2026-06-08T04:10:26.356714+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Neuraxis secures $3M financing via Series B preferred stock at $2.38/share

## Summary
- Aggregate purchase price $3,000,000; paid in 15 monthly installments of $200,000 each.
- Transaction subject to stockholder approval of Series B Preferred Stock amendment.
- Series B convertible into common stock; ranks senior to common on liquidation.
- Funds to support sales/marketing for IB-Stim™ and launch of RED device in 2024.
- Investor is Flagstaff International, an affiliate of Inspire Health Alliance.

## SEC filing metadata
- accession: 0001493152-23-040826
- form_type: 8-K
- ticker: NRXS
- cik: 0001933567
- company_name: Neuraxis, INC
- filed_at: 2023-11-14T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1933567/000149315223040826/0001493152-23-040826-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1933567/000149315223040826/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-040826
- JSON: https://secwatch.observer/filing/0001493152-23-040826.json
- Plain text: https://secwatch.observer/filing/0001493152-23-040826.txt

## Key facts
- Material Agreements
  Neuraxis, INC entered into SPA with Flagstaff International, LLC valued at $3,000,000 (effective 2023-11-09).
  - Action: entry
  - Agreement: equity purchase
  - Counterparty: Flagstaff International, LLC
  - Value: $3,000,000
  - Effective: 2023-11-09
  source text: On November 9, 2023, Neuraxis, Inc. (the “Company”) entered into a securities purchase agreement (the “SPA”) with Flagstaff International, LLC ( “Flagstaff International”) for the issuance and purchase of the Company’s Series B Convertible Preferred Stock, par value $0.001 per share (the “Series B Preferred Stock”), at price per share of $2.38. The aggregate purchase price is $3,000,000
  evidence_url: https://www.sec.gov/Archives/edgar/data/1933567/000149315223040826/0001493152-23-040826-index.htm
- Material Agreements
  Neuraxis, INC entered into Registration Rights Agreement with Flagstaff International (effective 2023-11-09).
  - Action: entry
  - Counterparty: Flagstaff International
  - Effective: 2023-11-09
  source text: In connection with the SPA, the Company entered into a Registration Rights Agreement (the “Registration Rights Agreement”) with Flagstaff International.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1933567/000149315223040826/0001493152-23-040826-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.